27-Oct-2026 12:37:38
THYROCARE ; CO EXPLORING MERGER WITH PARENT PHARMEASY - ETNOW
API Holdings owns a controlling ~51% equity stake in Thyrocare Technologies The plan, if successful, may see Thyrocare reverse-merge with PharmEasy ALERT: API Holdings operates and owns the PharmEasy brand PharmEasy is one of India's biggest digital pharmacies PharmEasy's services include treatment and drug deliveries, diagnostics and online teleconsultations Its offerings also include home collection of test samples for delivery to its labs Thyrocare Technologies offers online and automated medical lab tests and diagnostic services API Holdings withdrew an earlier IPO proposal in 2022 On July 13, ET NOW reported that API Holdings was exploring options to revive the listing of its shares The merger plan being explored seeks to streamline group operations and bring the brands under a single operating company
THYROCARE TECH LTD